Unlearn

What is Unlearn?

Unlearn AI is a California-based company at the forefront of utilizing AI to revolutionize healthcare and clinical drug development. Their cutting-edge technology involves the development and deployment of generative machine learning methods that create patient digital twins. These digital twins simulate potential health outcomes and predict individual health trajectories, contributing significantly to personalized medicine. Unlearn AI's approach accelerates clinical trials by forecasting patient health changes over time, estimating treatment effects, and aiding in speedy enrollment in AI-powered trials. By eliminating the trial and error process in medicine, Unlearn AI enhances the efficiency of clinical research, particularly in fields such as neuroscience, immunology, and metabolic diseases.

Who created Unlearn?

Unlearn was created by a California-based company that develops and deploys AI to accelerate clinical drug development. The company was founded by individuals who aimed to eliminate trial and error in medicine by utilizing generative machine learning methods to simulate potential health futures and predict individual health outcomes through patient digital twins. Unlearn was launched on June 17, 2024.

Who is Unlearn for?

• Clinical researcher
• Data Scientist
• Biostatistician
• Pharmaceutical Scientist
• Neuroscientist
• Immunologist
• Medical Doctor
• Health Economist
• Regulatory Affairs Specialist
• Clinical Trial Manager

How to use Unlearn?

To use Unlearn's AI tool effectively, follow these steps:

1. Data Collection: Begin by gathering the participant's baseline data.

2. Digital Twins Creation: Utilize the AI model trained on historical data to create the participant's 'Digital Twin'. This twin serves as a simulation of potential future health outcomes based on the collected data.

3. Simulation and Forecasting: The 'Digital Twins' tool allows you to simulate 'what if?' scenarios by predicting potential health outcomes for the participant. This forecasting aids in understanding the effects of different treatments.

4. Personalized Medicine: Embrace the digital twins' capability to enhance personalized medicine by tailoring treatment plans to individual patients based on the simulated outcomes.

5. Clinical Trial Assistance: Use the tool in various medical fields like neuroscience, immunology, and metabolic diseases to expedite clinical trials' enrollment process and observe treatment effects effectively.

6. Decision-Making Support: Leverage the prognostic scores provided by the tool during randomized clinical trials to enhance the analysis and adhere to regulatory guidelines.

By following these steps, you can effectively utilize Unlearn's AI tool to simulate potential health outcomes, accelerate clinical trials, and contribute to personalized medicine within diverse medical fields.